Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations

Fertility and Sterility

Volumn 104, Issue 1, 2015, Pages 154-162.e2

  Fonseca, Dora Janeth ^a   Patiño, Liliana Catherine ^a   Suárez, Yohjana Carolina ^a   De Jesús Rodríguez, Asid ^a   Mateus, Heidi Eliana ^a   Jiménez, Karen M ^a   Ortega Recalde, Oscar ^a   Díaz Yamal, Ivonne ^b   Laissue, Paul ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b Hospital Clínica de Marly   (Colombia)

Author keywords

ADAMTS19; BMPR2; next generation sequencing; POF; Premature ovarian failure

Indexed keywords

ADAMTS19 GENE; ADULT; ARTICLE; BIOINFORMATICS; BMPR2 GENE; CASE CONTROL STUDY; COHORT ANALYSIS; COMPUTER MODEL; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; LHCGR GENE; MAJOR CLINICAL STUDY; MENOPAUSE; NEXT GENERATION SEQUENCING; PHENOTYPE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SANGER SEQUENCING; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; SEQUENCE ANALYSIS;

ADAM PROTEIN; ADAMTS19 PROTEIN, HUMAN; BMPR2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

ADAM PROTEINS; ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; PRIMARY OVARIAN INSUFFICIENCY; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS;

EID: 84937520289     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.04.016     Document Type: Article

References (66)

1. L. Cox, and J.H. Liu Primary ovarian insufficiency: an update Int J Womens Health 6 2014 235 243
2. C.B. Coulam Premature gonadal failure Fertil Steril 38 1982 645 655
3. L.S. Timmreck, and R.H. Reindollar Contemporary issues in primary amenorrhea Obstet Gynecol Clin North Am 30 2003 287 302
4. A.R. Zinn, and J.L. Ross Turner syndrome and haploinsufficiency Curr Opin Genet Dev 8 1998 322 327
5. S.L. Sherman Premature ovarian failure in the fragile X syndrome Am J Med Genet 97 2000 189 194
6. P. Laissue, G. Vinci, R.A. Veitia, and M. Fellous Recent advances in the study of genes involved in non-syndromic premature ovarian failure Mol Cell Endocrinol 282 2008 101 111
7. K. Aittomäki, J.L. Lucena, P. Pakarinen, P. Sistonen, J. Tapanainen, J. Gromoll, and et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure Cell 82 1995 959 968
8. A.C. Latronico, J. Anasti, I.J. Arnhold, R. Rapaport, B.B. Mendonca, W. Bloise, and et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene N Engl J Med 334 1996 507 512
9. I. Beau, P. Touraine, G. Meduri, A. Gougeon, A. Desroches, C. Matuchansky, and et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor J Clin Invest 102 1998 1352 1359
10. P. Touraine, I. Beau, A. Gougeon, G. Meduri, A. Desroches, C. Pichard, and et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype Mol Endocrinol 13 1999 1844 1854
11. A. Rannikko, P. Pakarinen, P.R. Manna, I. Beau, M. Misrahi, K. Aittomäki, and et al. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation Mol Hum Reprod 8 2002 311 317
12. E. Doherty, P. Pakarinen, A. Tiitinen, A. Kiilavuori, I. Huhtaniemi, S. Forrest, and et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure J Clin Endocrinol Metab 87 2002 1151 1155
13. E. Di Pasquale, P. Beck-Peccoz, and L. Persani Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene Am J Hum Genet 75 2004 106 111
14. Y. Qin, Y. Choi, H. Zhao, J.L. Simpson, Z.-J. Chen, and A. Rajkovic NOBOX homeobox mutation causes premature ovarian failure Am J Hum Genet 81 2007 576 581
15. H. Zhao, Z.-J. Chen, Y. Qin, Y. Shi, S. Wang, Y. Choi, and et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure Am J Hum Genet 82 2008 1342 1348
16. D. Lourenço, R. Brauner, L. Lin, A. De Perdigo, G. Weryha, M. Muresan, and et al. Mutations in NR5A1 associated with ovarian insufficiency N Engl J Med 360 2009 1200 1210
17. R. Rossetti, E. Di Pasquale, A. Marozzi, S. Bione, D. Toniolo, P. Grammatico, and et al. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein Hum Mutat 30 2009 804 810
18. X. Wu, B. Wang, Z. Dong, S. Zhou, Z. Liu, G. Shi, and et al. A NANOS3 mutation linked to protein degradation causes premature ovarian insufficiency Cell Death Dis 4 2013 e825
19. S. Caburet, V.A. Arboleda, E. Llano, P.A. Overbeek, J.L. Barbero, K. Oka, and et al. Mutant cohesin in premature ovarian failure N Engl J Med 370 2014 943 949
20. M.G. Santos, A.Z. Machado, C.N. Martins, S. Domenice, E.M. Costa, M.Y. Nishi, and et al. Homozygous inactivating mutation in NANOS3 in two sisters with primary ovarian insufficiency Biomed Res Int 2014 2014 787465
21. E. Hodges, Z. Xuan, V. Balija, M. Kramer, M.N. Molla, S.W. Smith, and et al. Genome-wide in situ exon capture for selective resequencing Nat Genet 39 2007 1522 1527
22. T.J. Albert, M.N. Molla, D.M. Muzny, L. Nazareth, D. Wheeler, X. Song, and et al. Direct selection of human genomic loci by microarray hybridization Nat Methods 4 2007 903 905
23. K.M. Boycott, M.R. Vanstone, D.E. Bulman, and A.E. MacKenzie Rare-disease genetics in the era of next-generation sequencing: discovery to translation Nat Rev Genet 14 2013 681 691
24. A. Kiezun, K. Garimella, R. Do, N.O. Stitziel, B.M. Neale, P.J. McLaren, and et al. Exome sequencing and the genetic basis of complex traits Nat Genet 44 2012 623 630
25. D.C. Koboldt, K.M. Steinberg, D.E. Larson, R.K. Wilson, and E.R. Mardis The next-generation sequencing revolution and its impact on genomics Cell 155 2013 27 38
26. D. Shyr, and Q. Liu Next generation sequencing in cancer research and clinical application Biol Proced Online 15 2013 4
27. L.A. Lange, Y. Hu, H. Zhang, C. Xue, E.M. Schmidt, Z.-Z. Tang, and et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol Am J Hum Genet 94 2014 233 245
28. O. Ortega-Recalde, J.I. Vergara, D.J. Fonseca, X. Ríos, H. Mosquera, O.M. Bermúdez, and et al. Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology PLoS One 8 2013 e64692
29. L.C. Patiño, R. Battu, O. Ortega-Recalde, J. Nallathambi, V.R. Anandula, U. Renukaradhya, and et al. Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis PLoS One 9 2014 3 7
30. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, and et al. A method and server for predicting damaging missense mutations Nat Methods 7 2010 248 249
31. P.C. Ng, and S. Henikoff SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res 31 2003 3812 3814
32. N. Santoro Update in hyper- and hypogonadotropic amenorrhea J Clin Endocrinol Metab 96 2011 3281 3288
33. M.M. Matzuk, and D.J. Lamb Genetic dissection of mammalian fertility pathways Nat Cell Biol 4 Suppl 2002 s41 s49
34. A. Roy, and M.M. Matzuk Deconstructing mammalian reproduction: using knockouts to define fertility pathways Reproduction 131 2006 207 219
35. M.M. Matzuk, and D.J. Lamb The biology of infertility: research advances and clinical challenges Nat Med 14 2008 1197 1213
36. K. Jagarlamudi, P. Reddy, D. Adhikari, and K. Liu Genetically modified mouse models for premature ovarian failure (POF) Mol Cell Endocrinol 315 2010 1 10
37. K. Jagarlamudi, and A. Rajkovic Oogenesis: transcriptional regulators and mouse models Mol Cell Endocrinol 356 2012 31 39
38. S. Cal, A.J. Obaya, M. Llamazares, C. Garabaya, V. Quesada, and C. López-Otín Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains Gene 283 2002 49 62
39. S. Porter, I.M. Clark, L. Kevorkian, and D.R. Edwards The ADAMTS metalloproteinases Biochem J 386 2005 15 27
40. S.S. Apte A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms J Biol Chem 284 2009 31493 31497
41. A.C. Nicholson, S.-B. Malik, J.M. Logsdon, and E.G. Van Meir Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization BMC Evol Biol 5 2005 11
42. D.B. Menke, and D.C. Page Sexually dimorphic gene expression in the developing mouse gonad Gene Expr Patterns 2 2002 359 367
43. K.S. McClelland, E.N. Wainwright, J. Bowles, and P. Koopman Rapid screening of gene function by systemic delivery of morpholino oligonucleotides to live mouse embryos PLoS One 10 2015 e0114932
44. G.J. Bouma, G.T. Hart, L.L. Washburn, A.K. Recknagel, and E.M. Eicher Using real time RT-PCR analysis to determine multiple gene expression patterns during XX and XY mouse fetal gonad development Gene Expr Patterns 5 2004 141 149
45. P. Lu, K. Takai, V.M. Weaver, and Z. Werb Extracellular matrix degradation and remodeling in development and disease Cold Spring Harb Perspect Biol 3 2011
46. E.A. Knauff, L. Franke, M.A. van Es, L.H. van den Berg, Y.T. van der Schouw, J.S. Laven, and et al. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene Hum Reprod 24 2009 2372 2378
47. J.A. Pyun, S. Kim, D.H. Cha, and K. Kwack Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure Hum Reprod 28 2013 3146 3154
48. J.A. Pyun, S. Kim, and K. Kwack Epistasis between polymorphisms in ACVR2B and ADAMTS19 is associated with premature ovarian failure Menopause 22 2015 212 216
49. T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D.H. Wolsing, and et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors J Biol Chem 270 1995 22522 22526
50. F. Liu, F. Ventura, J. Doody, and J. Massagué Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs Mol Cell Biol 15 1995 3479 3486
51. H. Chang, C.W. Brown, and M.M. Matzuk Genetic analysis of the mammalian transforming growth factor-beta superfamily Endocr Rev 23 2002 787 823
52. S. Shimasaki, R.K. Moore, F. Otsuka, and G.F. Erickson The bone morphogenetic protein system in mammalian reproduction Endocr Rev 25 2004 72 101
53. J. Massagué, J. Seoane, and D. Wotton Smad transcription factors Genes Dev 19 2005 2783 2810
54. R.K. Moore, F. Otsuka, and S. Shimasaki Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells J Biol Chem 278 2003 304 310
55. M.M. Pulkki, D.G. Mottershead, A.H. Pasternack, P. Muggalla, H. Ludlow, M. van Dinther, and et al. A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells Endocrinology 153 2012 1509 1518
56. J. Peng, Q. Li, K. Wigglesworth, A. Rangarajan, C. Kattamuri, R.T. Peterson, and et al. Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions Proc Natl Acad Sci U S A 110 2013 E776 E785
57. P. Laissue, S. Christin-Maitre, P. Touraine, F. Kuttenn, O. Ritvos, K. Aittomaki, and et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure Eur J Endocrinol 154 2006 739 744
58. R.D. Machado, N. Rudarakanchana, C. Atkinson, J.A. Flanagan, R. Harrison, N.W. Morrell, and et al. Functional interaction between BMPR-II and Tctex-1, a light chain of dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension Hum Mol Genet 12 2003 3277 3286
59. V.C. Foletta, M.A. Lim, J. Soosairaiah, A.P. Kelly, E.G. Stanley, M. Shannon, and et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 J Cell Biol 162 2003 1089 1098
60. S. Hassel, A. Eichner, M. Yakymovych, U. Hellman, P. Knaus, and S. Souchelnytskyi Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry Proteomics 4 2004 1346 1358
61. K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips, J.E. Loyd, and et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension Nat Genet 26 2000 81 84
62. Z. Deng, F. Haghighi, L. Helleby, K. Vanterpool, E.M. Horn, R.J. Barst, and et al. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33 Am J Respir Crit Care Med 161 2000 1055 1059
63. R.D. Machado, M.A. Aldred, V. James, R.E. Harrison, B. Patel, E.C. Schwalbe, and et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension Hum Mutat 27 2006 121 132
64. W. Li, B.J. Dunmore, and N.W. Morrell Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension Proc Am Thorac Soc 7 2010 395 398
65. L. Ma, and W.K. Chung The genetic basis of pulmonary arterial hypertension Hum Genet 133 2014 471 479
66. Y. Bentov, S. Kenigsberg, and R.F. Casper A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss Fertil Steril 97 2012 1165 1168